M&A Update – Dec 9

– IPG to be acquired by OMC for 0.344x shares, 21.6% premium, $16.1 billion
– PTVE to be acquired by Novolex for $18.00 cash per share, 22.6% premium, $6.7 billion
– EBTC to be acquired by INDB for $2.00 cash + 0.60x shares, 23.6% premium, $562 million
– RVNC / Crown Laboratories entered amended merger agreement at $3.10 cash per share, down -53.5% from $6.66, closing Q1 2025, tender expected to commence Dec 12
– CTLT / Novo Holdings cleared EC, closing near end of 2024
– ATSG go-shop expires
– SMAR vote